Navigation Links
California Biomedical Industry Leaders Urge Congress to Take Action on FDA User Fees for FY2014
Date:5/24/2013

(LA JOLLA, Calif.) (PRWEB) May 24, 2013

CHI-California Healthcare Institute today submitted a letter to House Appropriators and the California congressional delegation, joined by over 40 biomedical companies, urging them to restore sequestered industry user fees paid to the U.S. Food and Drug Administration in 2013, and to ensure that future across-the-board cuts will not include user fees paid to FDA, as part of the FY14 Agriculture, Rural Development and FDA Appropriations Bill. CHI is a non-profit public policy research and advocacy organization for California’s biomedical R&D industry.

California is the worldwide leader in biomedical investment, research and development, with more than 2,300 biomedical companies and public and private research institutions advancing scientific knowledge and developing new diagnostics tools, treatments, and technologies addressing diseases and conditions including cancer, diabetes, HIV/AIDS, chronic pain, and cardiovascular, respiratory and infectious diseases.

Last year, Congress passed the FDA Safety and Innovation Act (FDASIA) which renewed the FDA’s authority to collect user fees from industry. These funds were to provide much-needed improvements to drug and device regulatory review processes. CHI supported this important legislation, as it was developed with input from the industry, the Agency, patient groups and other stakeholders, and signed into law with overwhelming and bipartisan support.

Unfortunately, congressionally-mandated across-the-board spending cuts now threaten the implementation of the FDASIA legislation, which could lead to a slowdown at FDA, with delays in patient access to innovative new technologies and further aggravating an already significant downturn in life sciences venture capital investment. Specifically, sequestration prevents FDA from accessing and using nearly $83 million in industry-paid user fees to conduct review activities and make the necessary regulatory process improvements.

“As lawmakers begin to prioritize funding measures for FY14, it is essential that we safeguard the budget of the U.S. Food and Drug Administration,” said David L. Gollaher, Ph.D., CHI’s president and CEO. “Industry user fees are critical for the FDA to complete timely and effective reviews of new medical devices and medicines. We urge legislators in Washington to repair this unacceptable sequester of user fees, by restoring to the FDA all user fees paid in 2013, and also to take steps to ensure future cuts do not affect user fees paid to the FDA in the future.”

As California’s biomedical industry is an increasingly important component of our state’s economic engine, employing nearly 270,000 people, paying $15.5 billion in wages and accounting for $20 billion in exports annually, user fees are critical for FDA to meet its Congressionally-mandated responsibilities, and are also important for sustaining biomedical investment, innovation and improvements in patient care.

“We believe that the vibrancy of California’s biomedical industry depends heavily upon continued advances and progress in science, which are supported by a well-funded, science-based FDA,” said CHI President and CEO David L. Gollaher, Ph.D. “User fees contribute greatly to ensuring that the FDA is able to provide vigorous, predictable and efficient product reviews, which are necessary for biomedical investment, innovation and improvements in patient care.”

Click here to view the letter sent to House Appropriators and the California congressional delegation.

About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare, Facebook, LinkedIn and YouTube.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10769522.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Majority of Californias Medi-Cal caregivers live in or near poverty
2. EB-5 Expert Brian Su Explores Chinese Inbound Investments in Southern California
3. Artisan Business Group hosts EB-5 Conference in California
4. Tracy, California Coast Dental Office Opens
5. Tragic San Diego Dog Attack Leaves One Infant Dead – California Dog Bite Attorneys Revive Pit Bull Warnings
6. Brian Su Hosts EB-5 Training Camp in California July 19, 2012
7. High-caliber “911-Level” Attendants Keep Rescue Alert of California™ Clients Safe
8. California Woman Finds Ways to Control IBS
9. Deadly Black Widow Spider Edged Aside in California
10. Recessions bite: Nearly 4 million Californians struggled to put food on table during downturn
11. What did we learn from the 2010 California whooping cough epidemic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... NEW ORLEANS, La. (PRWEB) , ... July 21, ... ... tool to allow 4th-year medical students improve their chances of acceptance to a ... particularly for those who have earned degrees outside the U.S. , According to ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is proud of ... her research center at Bio-Logic Aqua Research® Water Life Science®, has been released ... of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will contribute to ...
(Date:7/21/2017)... TORONTO, ONTARIO, CANADA (PRWEB) , ... July 21, ... ... with over 80% follow-up at 10 years, researchers from the Multicenter Orthopaedics Outcome ... knee-related quality of life a decade after surgery, though activity levels decline over ...
(Date:7/21/2017)... CANADA (PRWEB) , ... July 21, 2017 , ... ... insight into why concussion rates are on the rise, say researchers presenting their ... today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns of ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... company focused on the development of oral drug delivery systems, ... Securities Authority to dual-list its common stock on the Tel ... on the TASE on July 12, 2017 under the ticker ... it is expected that Oramed will be included in the ...
(Date:7/5/2017)... , July 5, 2017   BioLife Solutions ... developer, manufacturer and marketer of proprietary clinical grade cell ... freeze media ("BioLife"), today announced that it has ... debt holder and largest shareholder, to modify its existing ... Pursuant to the modification, WAVI agreed to exchange its ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology: